Educational Workshops
2023 Info:
GENERAL SESSIONS
Intersectionality & Clinical Trials: The Role of Procurement
With the global pandemic, diversity, equity, and inclusion spotlights and FDA diversity requirements in clinical trials, challenges to resources, changes in the economy, etc., companies are changing the way they structure and run clinical trials, and R&D Procurement is helping to lead the way. We will learn from two leaders in this space how pharma and bio pharma are meeting these challenges.
Moderator:- JOYCE EGGERS, Takeda
Panelists:
- BRIGID SIEGEL, Takeda
- REHBAR TAYYABKHAN, Merck
BREAKOUT SESSIONS
Health Equity: Bridging the Disparity Gap
This session will highlight strategies and interventions that can be employed to achieve health equity and reduce disparities. This may include increasing access to quality healthcare, improving health literacy, enhancing social support systems, and promoting community engagement and participation. Overall, this session will provide participants with an understanding of the importance of health equity and the need to address disparities in healthcare. It will also provide practical solutions and approaches for bridging the gap and promoting equitable health outcomes for all populations. Come learn what actions corporations are taking to improve health equity, and how health equity ties to supplier diversity.
Moderator:- RAUL SUAREZ-RODRIGUEZ, Merck
Panelists:
- LINN PARRISH, Takeda
- XAVIOR ROBINSON, Merck
- JAMES SMITH, AstraZeneca
Scope 3 – Where do you Start?
As the global community seeks to address the urgent issue of climate change, there is an increasing demand for companies to take responsibility for their carbon footprint. Corporations, Governments, and regulating bodies are now requiring their suppliers to set ambitious Scope 3 targets, which cover the indirect emissions resulting from the supplier’s activities, including their supply chain. To help suppliers rise to this challenge, this panel will explore a range of solutions and resources that are available to them at no cost. From guidance on how to measure and manage Scope 3 emissions to tools for setting and achieving ambitious targets, attendees will leave this discussion equipped with the knowledge and resources they need to take meaningful action on climate change. By working together to tackle Scope 3 emissions, suppliers can help build a more sustainable and resilient future for all.
Moderator:- BRIDGET FERRARI, Takeda
Panelists:
- BARRY KULL, SR., AstraZeneca
- JIMMY FLEMING, Amgen
- DEVIN CARSDALE, Bristol Myers Squibb
Sustainability: what Corporations want and how to get started
Corporations demand their partners to develop new sustainable products and services to improve the sustainability of the supply chain. The panel will discuss procurement requirements, resources available to suppliers and share insights from two suppliers’ real-life experiences.
Corporate leaders are confronting a growing list of environmental and social issues that pose serious risks and opportunities for their businesses. They are looking to their suppliers to contribute to the value chain and help them meet their public commitments. Suppliers need the skills, knowledge, and tools to build an organization that has sustainable and innovative solutions to challenges such as climate change and societal inequities. Learn about the trends driving this new business imperative and how to incorporate the important environmental, social and governance (ESG) dimensions of sustainable business practice.
Objectives
- What is Sustainability and Why it is Important, and Why now
- Growing Supplier Expectations by the Corporates
- Sharing best practice how suppliers start and enhance their sustainability journey
Moderator:
- MARY FEHLIG, The Fehlig Group
Panelists:
- AMEDEO PINEDA, Teva Pharmaceuticals
- JENNIFER BEDDINGFIELD, Xavier Creative
- SHIRIN SWANSON, Nuco Logistics
Innovations and Trends in AI
According to estimates, the healthcare AI market will grow to over $45 billion by 2026. Now is the time for everyone involved in healthcare, including medical consumers and entrepreneurs, to understand and embrace the AI in healthcare revolution.
In this session we will explore Innovations and Trends in AI in the Pharma, Biotech, Life Sciences and Healthcare industry segment.
We will explore some new technologies like Cognitive Digital Twin, Large Language Models ( GPT-4), Generative AI and their impact on Supply Chain, Clinical Trials, Drug Discovery, Patient Engagement and Health Equity.
Participants will learn how AI can be leveraged in their business environment.
Panelists:
- ROHIT MAHAJAN, Managing Partner, BigR.io
- COREY THOMPSON, Chief Technology Officer, BigR.io
